Por: The Boston Globe Business March 01, 2023
A Boston biotech startup is developing a new class of gene editing technologies that could control how our genetic code is read without changing the code itself. Chroma Medicine, whose labs are in the Fenway neighborhood, announced Wednesday that it raised $135 million towards that goal, bringing the company’s total funds to $260 million since it was founded in 2020.Chroma’s approach, known as epigenetic editing, could have broad... + full article
The Boston Globe USA Business February 22, 2023
Moderna is aiming to build a gene editing franchise powered by some of the same technologies used in its COVID-19 vaccines. The Cambridge biotech company announced Wednesday that it will partner with Life Edit Therapeutics to develop potentially permanent treatments for rare... + más
Vor Biopharma says first patient given its gene editing therapy for leukemia is in remission | The Boston Globe
Opinion | The New York Times
Time USA Health January 14, 2023
It’s been 13 years in the making, but Dr. David Sinclair and his colleagues have finally answered the question of what drives aging. In a published Jan. 12 in Cell, Sinclair, a professor of genetics and co-director of the Paul F. Glenn Center for Biology of Aging Research at... + más
New research points to a way to reverse aging. But don’t expect a miracle drug anytime soon. | The Boston Globe
The new rules of aging well involve small but mighty daily decisions | MarketWatch
The Boston Globe USA Nation January 12, 2023
Scientists may be edging closer to unearthing a fountain of youth, announcing Thursday they had found a new model to explain how aging works — and how it might be reversed.A new study published in the scientific journal Cell shows how degradation in the way DNA is organized... + más
Scientists Have Reached a Key Milestone in Learning How to Reverse Aging | Time
Time USA Health December 08, 2022
Cardiovascular disease is the leading cause of death in the U.S. and around the world. Though it’s held the top spot for decades, it wasn’t always the king of mortal maladies. Its ascension was propelled by two of medical science’s greatest successes. “Before the 20th... + más
HDL or ‘good’ cholesterol might not make a difference to heart health: study | New York Post
Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’ | The Boston Globe
The Verge USA Tech November 15, 2022
Descript’s revamped video editing Storyboard feature launches for all usersDescript’s revamped video editing Storyboard feature launches for all users / Descript’s audio transcripts made editing much easier than using traditional timeline-based software. Now, the company... + más
TikTok update adds new tools to let users edit and adjust videos | 9to5Mac
Forbes USA Life October 16, 2022
A vampire facial isn't your typical trip to the esthetician—here's what to expect.getty Vampire facials aren’t new—they’ve been around for decades. However, thanks to celebrities and media coverage, the microneedling procedure has gained more attention—and... + más
Who wrote Interview with the Vampire? | Newsweek
'Interview with the Vampire' is a new series based on Anne Rice's bestselling horror novel — here's how to watch new episodes | Business Insider
The Boston Globe USA Business October 12, 2022
Competition is heating up among biotech startups building technologies that improve or expand upon what gene editing can do. While most of these firms are devising therapies that permanently modify DNA to treat, and potentially cure, genetic diseases, a growing number think that... + más
Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe
See the presentations that hot healthcare startups used to raise millions from top VCs | Business Insider
About iurex | Privacy Policy | Disclaimer |